A study of SOBI003 for the treatment of mucopolysaccharidosis type IIIA (Sanfilippo A syndrome).
Phase of Trial: Phase I
Latest Information Update: 24 Oct 2016
At a glance
- Drugs SOBI 003 (Primary)
- Indications Mucopolysaccharidosis III
- Focus Adverse reactions; Therapeutic Use
- 24 Oct 2016 New trial record
- 19 Oct 2016 According to a Swedish Orphan Biovitrum media release, company plans to initiate this trial in 2018.